Medical Center And Dispensaries Based Reporting

Objectives	- To enhance reporting from the ambulatory health system - To monitor communicable diseases by time, place and person - To detect alerts and outbreaks at local level
Sources of data	- Medical centers and dispensaries of the Ministry of Public Healht MOPH - Medical centers and dispensaries of the Ministry of Social Affairs MOSA - Other governemental medical centers and dispensaries - Medical centers and dispensaries of various Non-Governemetal Organizations NGO - Field medical units
Target diseases and syndromes	- Vaccine preventable diseases: acute flaccid paralysis, measles, rubella, pertussis (whooping cough) and mumps - For other communicable diseases: acute diarrhea, bloody/dysenteric diarrhea, cholera, acute jaundice, acute respiratory infection (including flu-like illness), unexplained fever, scabies and leishmania - Others: asthma, accidents/injuries
Guidelines	Medical center and dispensaries based surveillance guideline: Ar, En
Reporting form	Weekly reporting form
Results	- Latest weekly national bulletin

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A02BC05	ESOMEPRAZOLE BIOGARAN	G	Esomeprazole (magnesium dihydrate) - 40mg	40mg	Capsule, gastro-resistant	513,348 L.L
A02BC05	PRIMAZOL 40	G	Esomeprazole (magnesium dihydrate) - 40mg	40mg	Capsule, gastro-resistant	639,925 L.L
J02AC05	CRESEMBA	B	Isavuconazonium sulfate - 100mg	100mg	Capsule, hard	69,290,804 L.L
B01AE07	DAXATRAN	G	Dabigatran etexilate (mesilate) - 75mg	75mg	Capsule, hard	2,576,338 L.L
B01AE07	PRADAXA	B	Dabigatran etexilate (mesilate) - 110mg	110mg	Capsule, hard	1,603,204 L.L
B01AE07	PRADAXA	B	Dabigatran etexilate (mesilate) - 110mg	110mg	Capsule, hard	3,205,064 L.L
B01AE07	DAXATRAN	G	Dabigatran etexilate (mesilate) - 110mg	110mg	Capsule, hard	2,576,338 L.L
B01AE07	PRADAXA	B	Dabigatran etexilate (mesilate) - 150mg	150mg	Capsule, hard	3,031,709 L.L
B01AE07	DAXATRAN	G	Dabigatran etexilate (mesilate) - 150mg	150mg	Capsule, hard	2,576,338 L.L
L01ED03	ALECENSA	B	Alectinib - 150mg	150mg	Capsule, hard	L.L
A07AX03	NIFUNAL	G	Nifuroxazide - 200mg	200mg	Capsule, hard	217,702 L.L
L01EF01	PAPILLIO	G	Palbociclib - 100mg	100mg	Capsule, hard	L.L
L01EX08	LENVIMA	B	Lenvatinib - 10mg	10mg	Capsule, hard	L.L
L04AX04	ERVALI	G	Lenalidomide - 5mg	5mg	Capsule, hard	37,370,561 L.L
L01EX08	LENVIMA	B	Lenvatinib - 4mg	4mg	Capsule, hard	L.L
L04AX04	LENALIDOMIDE SPC	G	Lenalidomide - 5mg	5mg	Capsule, hard	71,647,217 L.L
L04AX04	LENOMA	G	Lenalidomide - 5mg	5mg	Capsule, hard	68,908,116 L.L
L04AX04	ERVALI	G	Lenalidomide - 10mg	10mg	Capsule, hard	71,493,520 L.L
C09BB07	RAMIPRIL/AMLODIPINE GENERICON	G	Ramipril - 2.5mg, Amlodipine - 5mg		Capsule, hard	1,358,625 L.L
C09BB07	RAMIPRIL/AMLODIPINE GENERICON	G	Ramipril - 5mg, Amlodipine - 5mg		Capsule, hard	1,358,625 L.L
L04AX04	LENALIDOMIDE SPC	G	Lenalidomide - 10mg	10mg	Capsule, hard	75,120,146 L.L
C09BB07	RAMIPRIL/AMLODIPINE GENERICON	G	Ramipril - 10mg, Amlodipine - 5mg		Capsule, hard	1,358,625 L.L
C09BB07	RAMIPRIL/AMLODIPINE GENERICON	G	Ramipril - 10mg, Amlodipine - 10mg		Capsule, hard	1,358,625 L.L
L04AX04	LENOMA	G	Lenalidomide - 10mg	10mg	Capsule, hard	14,449,637 L.L
L01XG03	NINLARO	B	Ixazomib - 4mg	4mg	Capsule, hard	388,991,058 L.L
L01XG03	NINLARO	B	Ixazomib - 3mg	3mg	Capsule, hard	348,420,676 L.L
L04AX04	ERVALI	G	Lenalidomide - 15mg	15mg	Capsule, hard	74,977,720 L.L
L01XG03	NINLARO	B	Ixazomib - 2.3mg	2.3mg	Capsule, hard	272,619,919 L.L
L04AX04	LENOMA	G	Lenalidomide - 15mg	15mg	Capsule, hard	15,241,884 L.L
L04AX04	ERVALI	G	Lenalidomide - 25mg	25mg	Capsule, hard	81,147,769 L.L

Medical center and dispensaries based reporting